New pill could ease carcinoid syndrome Flare-Ups
NCT ID NCT05361668
First seen Oct 31, 2025 · Last updated May 08, 2026 · Updated 27 times
Summary
This study tested a new drug called paltusotine in 36 adults with carcinoid syndrome, a condition that can cause flushing and diarrhea. The goal was to see if the drug is safe and how the body processes it at different doses. Participants took either 40 mg or 80 mg daily, with dose adjustments allowed, and were monitored for side effects and drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOID SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Crinetics Study Site
Los Angeles, California, 90048, United States
-
Crinetics Study Site
Los Angeles, California, 90095, United States
-
Crinetics Study Site
Newport Beach, California, 92663, United States
-
Crinetics Study Site
Stanford, California, 94305, United States
-
Crinetics Study Site
Miami, Florida, 33136, United States
-
Crinetics Study Site
Iowa City, Iowa, 52242, United States
-
Crinetics Study Site
Lexington, Kentucky, 40506, United States
-
Crinetics Study Site
New Orleans, Louisiana, 70112, United States
-
Crinetics Study Site
Boston, Massachusetts, 02118, United States
-
Crinetics Study Site
Rochester, Minnesota, 55905, United States
-
Crinetics Study Site
New York, New York, 10029, United States
-
Crinetics Study Site
Stony Brook, New York, 11794, United States
-
Crinetics Study Site
Cleveland, Ohio, 44106, United States
-
Crinetics Study Site
Columbus, Ohio, 43210, United States
-
Crinetics Study Site
Houston, Texas, 77030, United States
-
Crinetics Study Site
CABA, Buenos Aires, C1180 AAX, Argentina
-
Crinetics Study Site
CABA, Buenos Aires, C1264AAA, Argentina
-
Crinetics Study Site
CABA, Buenos Aires, C1426ANZ, Argentina
-
Crinetics Study Site
CABA, C1017AAS, Argentina
-
Crinetics Study Site
CABA, C1425BGH, Argentina
-
Crinetics Study Site
Fortaleza, Ceará, 60430-275, Brazil
-
Crinetics Study Site
Rio de Janeiro, Rio de Janeiro, 20231-092, Brazil
-
Crinetics Study Site
Rio de Janeiro, Rio de Janeiro, 22281-100, Brazil
-
Crinetics Study Site
Criciúma, Santa Catarina, 88811508, Brazil
-
Crinetics Study Site
São Paulo, São Paulo, 01509-010, Brazil
-
Crinetics Study Site
Rio de Janeiro, 22061-080, Brazil
-
Crinetics Study Site
Toronto, M4N 3M5, Canada
-
Crinetics Study Site
Mexico City, Cuauhtemoc, 06100, Mexico
-
Crinetics Study Site
Querétaro City, Querétaro, 76000, Mexico
-
Crinetics Study Site
Querétaro City, Querétaro, 76070, Mexico
-
Crinetics Study Site
Katowice, 40-514, Poland
-
Crinetics Study Site
Warsaw, 02-351, Poland
-
Crinetics Study Site
Wroclaw, 53-413, Poland
-
Crinetics Study Site Peru #1
Lima, 15036, Peru
-
Crinetics Study Site Peru #2
Lima, 15036, Peru
Conditions
Explore the condition pages connected to this study.